Aardvark Therapeutics, Inc.
AARD
$8.49
-$0.50-5.56%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -36.64M | -27.72M | -20.59M | -13.85M | -11.78M |
| Total Depreciation and Amortization | -18.00K | -31.00K | -34.00K | 15.00K | -46.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 995.00K | 931.00K | 962.00K | 867.00K | 1.45M |
| Change in Net Operating Assets | 2.75M | -465.00K | 1.57M | 1.45M | 1.23M |
| Cash from Operations | -32.91M | -27.29M | -18.09M | -11.52M | -9.15M |
| Capital Expenditure | -102.00K | -104.00K | -109.00K | -103.00K | -98.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -115.01M | -124.51M | -11.89M | -- | -- |
| Cash from Investing | -115.12M | -124.62M | -12.00M | -103.00K | -98.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 91.52M | 91.52M | 332.00K | 169.00K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 0.00 | 85.00M | 85.00M | 85.00M | 85.00M |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -3.67M | -5.65M | -3.34M | -2.16M | -2.06M |
| Cash from Financing | 87.85M | 170.87M | 81.99M | 83.01M | 82.94M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -60.18M | 18.96M | 51.91M | 71.39M | 73.70M |